156 results

• Wegovy Vision Loss Risks 5 Times Higher Than Ozempic: Study

  March 13, 2026

  Irvin Jackson

  A new study links higher doses of semaglutide, the active ingredient in Ozempic and Wegovy, with increased vision loss risks, with Wegovy carrying five times the risk than Ozempic.

• GLP-1 Gout and Bone Fracture Risks Highlighted in New Studies

  March 10, 2026

  Irvin Jackson

  Two new studies warn that Ozempic, Mounjaro and similar drugs may be linked to increased risks of bone density loss, osteoporosis and gout, particularly in older patients.

• Judge Appoints Attorneys to Leadership Positions in GLP-1 Vision Loss Lawsuits

  February 26, 2026

  Irvin Jackson

  A U.S. District Judge has appointed a group of 16 attorneys to work for the benefit of all plaintiffs with pending federal GLP-1 vision loss lawsuits.

• Study Finds No Link Between Side Effects of GLP-1s and Thyroid Cancer

  February 24, 2026

  Irvin Jackson

  A new report dismisses concerns linking drugs like Ozempic and Mounjaro to increased thyroid cancer risks, despite the drugs carrying a black box warning from the FDA.

• Ozempic, Wegovy NAION Risks Twofold Higher Compared to SGLT2i Drugs: Study

  February 19, 2026

  Irvin Jackson

  Researchers from Veterans' Affairs say that drugs like Ozempic and Wegovy carry double the risk of vision problems than other types of diabetes medications.

• GLP-1 Vision Loss Lawsuits Can Now Be Filed Directly in MDL Court

  February 2, 2026

  Irvin Jackson

  A federal judge has approved direct filing of new GLP-1 vision loss lawsuits with the MDL court in the Eastern District of Pennsylvania.

• FDA To Remove Suicide Risks From GLP-1 Side Effects Warnings

  January 15, 2026

  Irvin Jackson

  Federal regulators are asking manufacturers of GLP-1 weight loss drugs like Wegovy and Zepbound to remove warning labels linking the medications to increased suicide risks, saying they found no proof such risks exist.

• Judge Overseeing Ozempic Blindness Lawsuits Meeting With Lawyers for Initial Conference

  January 13, 2026

  Irvin Jackson

  Parties involved with Ozempic blindness lawsuits will meet with a federal judge overseeing the litigation for the first time on January 13.

• Link Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026

  December 23, 2025

  Irvin Jackson

  A federal judge has scheduled a series of deadlines designed to eliminate issues preventing GLP-1 lawsuits from moving forward with bellwether trials.

• Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL

  December 18, 2025

  Irvin Jackson

  All Ozempic and Wegovy vision loss lawsuits have been consolidated before the same federal judge overseeing related claims alleging stomach paralysis linked to the medications.